Merck KGaA (XSWX:MER) Cash per Share: CHF7.90 (As of Mar. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is Merck KGaA Cash per Share?

Merck KGaA XSWX:MER 84 Cash per Share is CHF7.90 as of Mar. 2026. GuruFocus rates XSWX:MER with a GF Score™ of 84/100 and a GF Value™ of CHF134.55. The stock has 10 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Merck KGaA's Cash per Share for the quarter that ended in Mar. 2026 was CHF7.90.

Merck KGaA (XSWX:MER) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Merck KGaA Cash per Share Related Terms

Merck KGaA Cash per Share Historical Data

* Premium members only.

The historical data trend for Merck KGaA's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck KGaA Cash per Share Chart

Merck KGaA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Cash per Share

Get a 7-Day Free Trial

3.89

3.73

4.36

5.82

6.28

Merck KGaA Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Cash per Share	Get a 7-Day Free Trial															3.56	3.39	6.28	6.28	7.90

84GF Score

Merck KGaA XSWX:MER

Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Merck KGaA Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Merck KGaA's Cash per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	2729.429	/	435
	=	6.28

Merck KGaA's Cash per Share for the quarter that ended in Mar. 2026 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	3434.994	/	435
	=	7.90

Frequently Asked Questions Learn more about Cash per Share →

What does a Cash per Share of CHF7.90 mean?

Merck KGaA (XSWX:MER) has a Cash per Share of CHF7.90 as of Mar. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Merck KGaA and its competitors.

Is Merck KGaA's Cash per Share too high?

Merck KGaA's current Cash per Share is CHF7.90. Overall, Merck KGaA has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.

How does Merck KGaA's Cash per Share compare to ZTS and UTHR?

Merck KGaA's Cash per Share of CHF7.90 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Cash per Share for a Drug Manufacturers company?

A good Cash per Share depends on the Drug Manufacturers industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Cash per Share mean?

A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Merck KGaA and its competitors. Merck KGaA's current Cash per Share is CHF7.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Merck KGaA stock overvalued right now?

Merck KGaA (XSWX:MER) has a current Cash per Share of CHF7.90. The stock's GF Value™ is CHF134.55, compared to a current price of CHF130.30 — trading 3.2% below its estimated fair value. The current Cash per Share is CHF7.90. Merck KGaA's overall GF Score™ is 84/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Cash per Share calculated?

Cash per Share is calculated from a company's financial statements. For Merck KGaA (XSWX:MER), the current Cash per Share is CHF7.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck KGaA (XSWX:MER) Overvalued in 2026?

Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued. The current stock price of CHF130.30 is trading 3.2% below its estimated GF Value™ of CHF134.55.

Key valuation signals for XSWX:MER:

Cash per Share: CHF7.90
GF Value™: CHF134.55 vs. price of CHF130.30 (3.2% below fair value)
GF Score™: 84/100 with 10 warning signs

No single metric tells the full story. See the XSWX:MER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merck KGaA Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XTER:EVT XTER:B8FK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR HKSE:03692 VTRS NSE:DIVISLAB OSTO:SOBI NBIX NSE:TORNTPHARM SHSE:688506 XPAR:IPN TSE:4507

Other Exchanges MKKGY:USA MKGAF:USA 1MRK:Italy MRKd:UK 0O14:UK MRK:Germany MRCK:Austria

Address Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293

Website https://www.merckgroup.com

Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

84GF Score

Get the complete analysis for XSWX:MER

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF130.30

Price

CHF134.55

GF Value

View XSWX:MER Analysis

See Cash per Share data for all stocks →